Adverse Events Seen With Combination Lenvatinib and Pembrolizumab for Recurrent Endometrial Cancer

Commentary
Video

Kimberly A. Spickes, CNP, details the adverse events she sees with combination lenvatinib and pembrolizumab treatment for recurrent endometrial cancer.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Recent Videos
Image of a man in a suit smiling in front of an Oncology Nursing News background
Gynecologic Cancers